Scholarly record
SEMISOLID PHARMACEUTICAL PREPARATIONS BASED ON METALLIC COMPLEX COMPOUNDS OF CHLORHEXIDINE SALTS WITH ANTIMICROBIAL ACTIVITY
Publication Impact Profile
Publication details
References30
Pal Barkvoll & Audun Attramadal, Effect of nystatin and chlorhexidine digluconate on Candida albicans, Oral Surgery, Oral Medicine, Oral Pathology , Volume 67, Issue 3, pp. 279–281, 1989.
US Patent 4980150 A/1990 - Chlorhexidine complex
Waler S. M. & Rolla G., Scandinavian Journal of Dental Research, 90(2), pp. 131- 133, 1982.
Gierstein E., Scheie A.A. & Rolla G., Scandinavian Journal of Dental Research, 96(6), pp. 541-550, 1988.
Young A., Jonski G. & Rolla G., European Journal of Oral Sciences, 111(5), pp. 400, 2003.
Greener B., Antimicrobial biguanide metal complexes, J. Pharmaceutical Sciences, 69(2), pp. 215-217, 2006.
Farrigton K.L. & Morrow L.E. Antimicrobial Metals: A Nonantibiotic Approach to Nosocomial Infections – Silver and copper may prove key in preventing a problem that kills nearly 88.000 per year, 2005.
Pal S., Yoon E.J., Yu Kyung Tak, Eung Chil Choi & Joon Myong Song, Synthesis of Highly Antibacterial Nanocrystalline Trivalent Silver Polydiguanide, J. Am. Chem. Soc. , 131, pp. 16147–16155, 2009.
Pal S., Yoon E.J., Park S.H., Choi E.C. & Song J.M., Metallopharmaceuticals based on silver(I) and silver(II) polydiguanide complexes: activity against burn wound pathogens, J Antimicrob Chemother, 65(10), pp. 2134-40, 2010.
Rafique S., Idrees M., Nasim A., Akbar H. & Athar A., Transition metal complexes as potential therapeutic agents, Biotechnology and Molecular Biology Reviews, Vol. 5(2), pp. 38-45, 2010.
Merenyi G., Eriksen T.E. & J. Lind. J. Biolum. and Chemilum., 5, pp. 53-56, 1990.
Cambell A.K. Chemiluminescence, principles and applications in biology and medicine, Ellis Horwood Ltd, Chechester, England, 1989.
***CLSI/NCCLS - Performance Standards for Antimicrobial Susceptibility Testing, Sixteenth Informational Supplement. CLSI/NCCLS document M100-S16. CLSI 940 West VaHey Road, Suite 1400, Wayne, PA 19087-1898 USA, 2006.
***Manual for the Laboratory Identification and Antimicrobial Susceptibilit y Testi ng of Bacterial Pathogens of Public Health Importance in the Developing World - WHO/ CDS/CSR/RMD/2003.6.
***EUCAST Definitive Document E. Def. 1.2 - Terminology related to methods for the determination of susceptibility of bacteria to antimicrobial agents - European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infection, 6, 9, 2000.
Pal Barkvoll & Audun Attramadal, Effect of nystatin and chlorhexidine digluconate on Candida albicans, Oral Surgery, Oral Medicine, Oral Pathology , Volume 67, Issue 3, pp. 279–281, 1989.
US Patent 4980150 A/1990 - Chlorhexidine complex
Waler S. M. & Rolla G., Scandinavian Journal of Dental Research, 90(2), pp. 131- 133, 1982.
Gierstein E., Scheie A.A. & Rolla G., Scandinavian Journal of Dental Research, 96(6), pp. 541-550, 1988.
Young A., Jonski G. & Rolla G., European Journal of Oral Sciences, 111(5), pp. 400, 2003.
Greener B., Antimicrobial biguanide metal complexes, J. Pharmaceutical Sciences, 69(2), pp. 215-217, 2006.
Farrigton K.L. & Morrow L.E. Antimicrobial Metals: A Nonantibiotic Approach to Nosocomial Infections – Silver and copper may prove key in preventing a problem that kills nearly 88.000 per year, 2005.
Pal S., Yoon E.J., Yu Kyung Tak, Eung Chil Choi & Joon Myong Song, Synthesis of Highly Antibacterial Nanocrystalline Trivalent Silver Polydiguanide, J. Am. Chem. Soc. , 131, pp. 16147–16155, 2009.
Pal S., Yoon E.J., Park S.H., Choi E.C. & Song J.M., Metallopharmaceuticals based on silver(I) and silver(II) polydiguanide complexes: activity against burn wound pathogens, J Antimicrob Chemother, 65(10), pp. 2134-40, 2010.
Rafique S., Idrees M., Nasim A., Akbar H. & Athar A., Transition metal complexes as potential therapeutic agents, Biotechnology and Molecular Biology Reviews, Vol. 5(2), pp. 38-45, 2010.
Merenyi G., Eriksen T.E. & J. Lind. J. Biolum. and Chemilum., 5, pp. 53-56, 1990.
Cambell A.K. Chemiluminescence, principles and applications in biology and medicine, Ellis Horwood Ltd, Chechester, England, 1989.
***CLSI/NCCLS - Performance Standards for Antimicrobial Susceptibility Testing, Sixteenth Informational Supplement. CLSI/NCCLS document M100-S16. CLSI 940 West VaHey Road, Suite 1400, Wayne, PA 19087-1898 USA, 2006.
***Manual for the Laboratory Identification and Antimicrobial Susceptibilit y Testi ng of Bacterial Pathogens of Public Health Importance in the Developing World - WHO/ CDS/CSR/RMD/2003.6.
***EUCAST Definitive Document E. Def. 1.2 - Terminology related to methods for the determination of susceptibility of bacteria to antimicrobial agents - European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infection, 6, 9, 2000.
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.

